CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- CORRESP Other Correspondence Between Filers and SEC Staff
- CERTNAS Other Certification by the Nasdaq Stock Market
- 8-A12B Other Registration of Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- S-1/A Offering Registration Statement
- AW Other AW
- UPLOAD Other SEC-generated Letter
- S-1/A Offering Registration Statement
- 4 Open-market buy SEE REMARKS bought 100 shares at $6.95 ($695)
- UPLOAD Other SEC-generated Letter
- 4 Open-market buy SEE REMARKS bought 100 shares at $7.25 ($725)
- 4 Open-market buy CFO and Treasurer bought 200 shares at $7.49 ($1,498)
- 4 Open-market buy SEE REMARKS bought 100 shares at $7.47 ($747)
- SC 13D Stake Beneficial Ownership Report
- 4 Open-market buy See Remarks bought 200 shares at $7.48 ($1,496)
- 4/A Open-market buy CFO and Treasurer bought 100 shares at $7.49 ($749)
Page 69 of 76 · 1,519 filings